Skip to main navigation Skip to search Skip to main content

US FDA approves Corstasis Therapeutics' Enbumyst to treat edema associated with congestive heart failure, liver disease and kidney disease

Press/Media

Period27 Sep 2025

Media coverage

2

Media coverage